Program
CHF-6467
Also written as “CHF6467 Part 1 (SAD)”, “CHF6467 Part 2 (MAD)” and “CHF6467 active”.
Its studies are mostly in Diabetic Foot, led by Chiesi Farmaceutici.
Drug pageCHF-6467: every studyAll 3 studies of it, academic ones too, with its approvals, label and forms.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Chiesi Farmaceutici | 21 open or running | phase 2since Mar 28, 2019 | Mar 28, 2019 | Feb 28, 2027phase 1 · NCT07163182 |
Also a collaborator on its studies: Comac Medical.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Mar 28, 2019First study: phase 2 study in Diabetic FootFirst studyNCT04077671 · 93 enrolled · Bulgaria
- Jul 24, 2025Phase 1 study in Healthy VolunteersNCT07163182 · 68 planned · Bulgaria
Ahead
- Feb 28, 2027Primary completion: phase 1 study in Healthy VolunteersNCT07163182
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 2 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07163182Healthy Volunteers · Bulgaria | 1 | Recruiting | Feb 28, 2027 | 68 |
| NCT04077671Diabetic Foot · Bulgaria | 2 | Completed | Jan 7, 2021 | 93 |
How it is read
Names in the registry
- “CHF6467 Part 1 (SAD)”, 1 entry
- “CHF6467 Part 2 (MAD)”, 1 entry
- “CHF6467 active”, 1 entry
Conditions, from the studies’ own filings
- Diabetic Foot, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.